Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

2.

Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.

L'Episcopo F, Tirolo C, Peruzzotti-Jametti L, Serapide MF, Testa N, Caniglia S, Balzarotti B, Pluchino S, Marchetti B.

Stem Cells. 2018 Aug;36(8):1179-1197. doi: 10.1002/stem.2827. Epub 2018 Apr 16.

3.

Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.

L'Episcopo F, Tirolo C, Serapide MF, Caniglia S, Testa N, Leggio L, Vivarelli S, Iraci N, Pluchino S, Marchetti B.

Front Aging Neurosci. 2018 Feb 12;10:12. doi: 10.3389/fnagi.2018.00012. eCollection 2018. Review.

4.

microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.

Leggio L, Vivarelli S, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Marchetti B, Iraci N.

Int J Mol Sci. 2017 Dec 13;18(12). pii: E2698. doi: 10.3390/ijms18122698. Review.

5.

Wnt3a promotes pro-angiogenic features in macrophages in vitro: Implications for stroke pathology.

Fuster-Matanzo A, Manferrari G, Marchetti B, Pluchino S.

Exp Biol Med (Maywood). 2018 Jan;243(1):22-28. doi: 10.1177/1535370217746392. Epub 2017 Dec 4.

6.

The role of the immune system in central nervous system plasticity after acute injury.

Peruzzotti-Jametti L, Donegá M, Giusto E, Mallucci G, Marchetti B, Pluchino S.

Neuroscience. 2014 Dec 26;283:210-221. doi: 10.1016/j.neuroscience.2014.04.036. Epub 2014 Apr 29. Review.

7.

Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.

L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Serapide MF, Pluchino S, Marchetti B.

Stem Cells. 2014 Aug;32(8):2147-63. doi: 10.1002/stem.1708.

8.

Regulating Wnt signaling: a strategy to prevent neurodegeneration and induce regeneration.

Harvey K, Marchetti B.

J Mol Cell Biol. 2014 Feb;6(1):1-2. doi: 10.1093/jmcb/mju002. No abstract available.

PMID:
24549156
9.

Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Morale MC, Serapide MF, Pluchino S, Marchetti B.

J Mol Cell Biol. 2014 Feb;6(1):13-26. doi: 10.1093/jmcb/mjt053. Epub 2014 Jan 14. Review.

10.

Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.

'Episcopo FL, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B.

Curr Aging Sci. 2013 Feb;6(1):45-55. Review.

PMID:
23895521
11.

Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair.

Marchetti B, L'Episcopo F, Morale MC, Tirolo C, Testa N, Caniglia S, Serapide MF, Pluchino S.

Eur J Neurosci. 2013 May;37(10):1550-63. doi: 10.1111/ejn.12166. Epub 2013 Mar 5. Review.

12.

Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation.

L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Impagnatiello F, Pluchino S, Marchetti B.

J Neurosci. 2013 Jan 23;33(4):1462-85. doi: 10.1523/JNEUROSCI.3206-12.2013.

13.

Wnt your brain be inflamed? Yes, it Wnt!

Marchetti B, Pluchino S.

Trends Mol Med. 2013 Mar;19(3):144-56. doi: 10.1016/j.molmed.2012.12.001. Epub 2013 Jan 9. Review.

14.
15.

Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.

L'episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Impagnatiello F, Marchetti B.

Rejuvenation Res. 2011 Aug;14(4):411-24. doi: 10.1089/rej.2010.1134. Epub 2011 Jul 27.

PMID:
21793734
16.

A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.

L'episcopo F, Serapide MF, Tirolo C, Testa N, Caniglia S, Morale MC, Pluchino S, Marchetti B.

Mol Neurodegener. 2011 Jul 13;6:49. doi: 10.1186/1750-1326-6-49.

17.

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Serra PA, Impagnatiello F, Morale MC, Marchetti B.

J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.

18.

Glia as a turning point in the therapeutic strategy of Parkinson's disease.

L' Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B.

CNS Neurol Disord Drug Targets. 2010 Jul;9(3):349-72. Review.

PMID:
20438439
19.

The MPTP mouse model: cues on DA release and neural stem cell restorative role.

Serra PA, Pluchino S, Marchetti B, Desole MS, Miele E.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S189-93. doi: 10.1016/j.parkreldis.2008.04.029. Epub 2008 Jun 24. Review.

PMID:
18579428
20.

Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?

Morale MC, L'Episcopo F, Tirolo C, Giaquinta G, Caniglia S, Testa N, Arcieri P, Serra PA, Lupo G, Alberghina M, Harada N, Honda S, Panzica GC, Marchetti B.

Brain Res Rev. 2008 Mar;57(2):431-43. Epub 2007 Nov 7. Review.

PMID:
18063054

Supplemental Content

Loading ...
Support Center